Navigation Links
MedImmune Announces Winners of Its 6th Annual Global Abstract Competition

GAITHERSBURG, Md., Nov. 14, 2011 /PRNewswire/ -- MedImmune today announced the winners of its 6th Annual Research Abstract Competition highlighting the work of the next generation of scientific leaders performing research in the areas of respiratory, inflammatory and autoimmune (RIA) disease. Graduate students and postdoctoral fellows were invited to submit abstracts about RIA research as part of a competition sponsored by MedImmune, the global biologics arm of AstraZeneca.

First prize of $2,000 was awarded to Philippe LeBlanc of Department of Medicine, McGill University, Montreal, Canada, for his research topic, Caspase-1 processes HMGB1 into an immunogenic peptide that signals through RAGE.

LeBlanc noted, "Thank you to all the friendly staff at MedImmune who organized this conference and provided an important opportunity for academia to interface with the private research sector. Many congratulations and thanks to the other participants for sharing their excellent work."

Second and third prizes of $1,000 and $500 were awarded respectively to Jillian Barlow, Laboratory of Molecular Biology, Medical Research Council, Cambridge, UK, and Xiangping Yang, Ph.D, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.

Launched in 2006, MedImmune's Annual Research Abstract Competition aims to engage emerging scientists in health and science education to cultivate a competitive environment that nurtures future research in key therapeutic areas. In 2009, following the success of the RIA abstract competition in the U.S., MedImmune introduced a similar effort in Europe to acknowledge advances in the field of oncology. Since its inception, the MedImmune Annual Research Competition has received more than 330 research abstracts from across the globe.

"We are continuously impressed with the quality of submissions put forth by these young scientists each year," said Bing Yao, Senior Vice President, R&D and RIA iMed Head. "As a company committed to innovation and scientific education, the Abstract Competition allows us to foster the growth of future scientists and recognize the emerging talent in the scientific community."

MedImmune selected ten finalists from the 80 abstract submissions received this year. Today, finalists presented their research to a panel of MedImmune judges at the company's headquarters in Gaithersburg, MD. The panel of six judges from MedImmune's RIA department then selected the winners. The evaluation of abstracts was based on the following criteria: scientific rationale, description of methodology, suitability of methods to aims, conclusions confirmed by objective results, ethics, scientific value, potential clinical value, originality of work and overall presentation.

About MedImmune

MedImmune, the global biologics arm for AstraZeneca PLC, has approximately 3,500 employees worldwide and is headquartered in Gaithersburg, Maryland. For more information, visit MedImmune's website at

SOURCE MedImmune
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Immune Design Grants Adjuvant License to MedImmune
2. MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology
3. Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors
4. HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)
5. MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor
6. MedImmune Announces Zook as President
7. MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
8. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
9. MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
10. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
11. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
Post Your Comments:
(Date:11/30/2015)... -- Northwest Biotherapeutics (NASDAQ: NWBO ) ("NW Bio"), a ... solid tumor cancers, announced today that the Board is ... Company welcomes Neil Woodford,s call for an ... report on NW Bio.  The Company,s Board is under ... stated, "We agree with Mr. Woodford that, at NW ...
(Date:11/27/2015)... Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: ... that it has closed the sale of its global ... (GBT- NYSE Euronext) in a transaction valued at approximately ... facilities and a total of approximately 1,000 employees spread ... St. Louis area. This entire workforce ...
(Date:11/26/2015)... , November 26, 2015 ... device company specializing in imaging technologies, announced today that it ... as part of the Horizon 2020 European Union Framework Programme ... a large-scale clinical trial in breast cancer. , ... , --> --> The ...
(Date:11/25/2015)... Studies reveal the differences in species of ... way for more effective treatment for one of the most ... --> --> Gum disease is ... yet relatively little was understood about the bacteria associated with ... by researchers from the WALTHAM Centre for Pet Nutrition together ...
Breaking Biology Technology:
(Date:10/29/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that it has been selected ... of only three finalists for a 2015 Tekne ... category. The Tekne Awards honor Minnesota ... and leadership. iMedNet™ eClinical  technology ...
(Date:10/29/2015)... , Oct. 29, 2015 Daon, a global ... it has released a new version of its ... North America have already installed ... also includes a FIDO UAF certified server component ... preparing to activate FIDO features. These customers include some ...
(Date:10/29/2015)...  Connected health pioneer, Joseph C. Kvedar , ... health and wellness, and the business opportunities that arise ... Internet of Healthy Things . Long before health ... Dr. Kvedar, vice president, Connected Health, Partners HealthCare, was ... care from the hospital or doctor,s office into the ...
Breaking Biology News(10 mins):